TG Therapeutics Q1 2025: Assets $158.7M, Liabilities $155.8M
Ticker: TGTX · Form: 10-Q · Filed: May 9, 2025 · CIK: 1001316
Sentiment: neutral
Topics: 10-Q, financials, lease obligations
TL;DR
TG Therapeutics Q1 2025: Assets $158.7M, Liabilities $155.8M. Cash $156.2M.
AI Summary
TG Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $158.7 million and total liabilities of $155.8 million for the quarter. Cash and cash equivalents stood at $156.2 million. The filing also details lease obligations and the incremental borrowing rates used for valuation.
Why It Matters
This filing provides a snapshot of TG Therapeutics' financial health, including its asset and liability position, which is crucial for investors and creditors to assess the company's stability and operational capacity.
Risk Assessment
Risk Level: medium — The company's liabilities are very close to its assets, indicating a tight financial position that could pose risks.
Key Numbers
- $158.7B — Total Assets (As of March 31, 2025, indicating the company's total resources.)
- $155.8B — Total Liabilities (As of March 31, 2025, representing the company's total obligations.)
- $156.2B — Cash and Cash Equivalents (As of March 31, 2025, showing the company's liquid assets.)
Key Players & Entities
- TG THERAPEUTICS, INC. (company) — Filer
- 20250331 (date) — Reporting period end date
- $158,736,286 (dollar_amount) — Total assets as of March 31, 2025
- $155,836,256 (dollar_amount) — Total liabilities as of March 31, 2025
- $156,204,159 (dollar_amount) — Cash and cash equivalents as of March 31, 2025
FAQ
What were TG Therapeutics' total assets as of March 31, 2025?
TG Therapeutics' total assets were $158,736,286 as of March 31, 2025.
What were TG Therapeutics' total liabilities as of March 31, 2025?
TG Therapeutics' total liabilities were $155,836,256 as of March 31, 2025.
How much cash and cash equivalents did TG Therapeutics have at the end of Q1 2025?
TG Therapeutics had $156,204,159 in cash and cash equivalents as of March 31, 2025.
What incremental borrowing rate was used for the NC lease?
An incremental borrowing rate of 5.65% was used for the NC lease.
What was the incremental borrowing rate used for operating leases that commenced prior to February 28, 2019, through December 31, 2021?
The incremental borrowing rate used for these operating leases was 10.25%.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding TG THERAPEUTICS, INC. (TGTX).